Information Provided By:
Fly News Breaks for September 2, 2015
KPTI
Sep 2, 2015 | 07:07 EDT
JPMorgan analyst Whitney Ijem started shares of Karyopharm Therapeutics with an Overweight rating and $20 price target citing the potential of selinexor in both heme and solid tumors..
News For KPTI From the Last 2 Days
There are no results for your query KPTI